Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis

PLoS ONE

Volumn 12, Issue 8, 2017, Pages

  Song, Rongjing ^a   Chen, Ling ^a   Chen, Yue ^a   Si, Xia ^a   Liu, Yi ^a   Liu, Yue ^a   Irwin, David M ^b,c   Feng, Wanyu ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT;

ARM CIRCUMFERENCE; ARTICLE; BIRTH INJURY; BIRTH WEIGHT; BODY MASS; CHEST CIRCUMFERENCE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEAD CIRCUMFERENCE; HIGH RISK INFANT; HUMAN; HYPOCALCEMIA; HYPOGLYCEMIA; INCIDENCE; LABOR INDUCTION; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MATERNAL AGE; META ANALYSIS; NEONATAL HYPERBILIRUBINEMIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; ORAL GLUCOSE TOLERANCE TEST; PERINATAL MORTALITY; POLYCYTHEMIA; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHOULDER DYSTOCIA; SMALL FOR DATE INFANT; STILLBIRTH; THIRD TRIMESTER PREGNANCY; TREATMENT OUTCOME; VAGINAL DELIVERY; WEIGHT GAIN; ADULT; CHEMICALLY INDUCED; COMPARATIVE STUDY; DIABETES, GESTATIONAL; DISEASE MANAGEMENT; DRUG EFFECTS; FEMALE; INFANT, NEWBORN, DISEASES; METHODOLOGY; NEWBORN; PREGNANCY;

ADULT; BIRTH WEIGHT; DIABETES, GESTATIONAL; DISEASE MANAGEMENT; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INSULIN; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 85026760425     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0182488     Document Type: Article

References (45)

1. Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010; 203(5):457.e1–9.
2. American Diabetes Association. Erratum. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes-2016. Diabetes Care 2016;39(Suppl. 1):S13-S22.
3. American Diabetes Association. Diabetes care. 2016; 39 (9):1653. https://doi.org/10.2337/dc16-er09 PMID: 27555625
4. Gupta Y, Kalra B, Baruah MP, Singla R, Kalra S. Updated guidelines on screening for gestational diabetes. Int J Womens Health. 2015; 7:539–50. https://doi.org/10.2147/IJWH.S82046 PMID: 26056493
5. de Seymour J, Chia A, Colega M, Jones B, McKenzie E, Shirong C, et al. Maternal Dietary Patterns and Gestational Diabetes Mellitus in a Multi-Ethnic Asian Cohort: The GUSTO Study. Nutrients. 2016; 8(9). pii: E574.
6. Pedersen ML, Olesen J, Jorgensen ME, Damm P. Gestational diabetes mellitus in Greenland: a national study of prevalence and testing efficacy. Int J Circumpolar Health. 2016; 75: 32167.
7. Huhn EA, Massaro N, Streckeisen S, Manegold-Brauer G, Schoetzau A, Schulzke SM, et al. Fourfold increase in prevalence of gestational diabetes mellitus after adoption of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. J Perinat Med. 2017; 45(3):359–66. https://doi.org/10.1515/jpm-2016-0099 PMID: 27508951
8. Koo BK, Lee JH, Kim J, Jang EJ, Lee CH. Prevalence of Gestational Diabetes Mellitus in Korea: A National Health Insurance Database Study. PLoS One 2016; 11(4): e0153107. https://doi.org/10.1371/journal.pone.0153107 PMID: 27046149
9. Meththananda Herath HM, Weerarathna TP, Weerasinghe NP. Is Risk Factor-based Screening Good Enough to Detect Gestational Diabetes Mellitus in High-Risk Pregnant Women? A Sri Lankan Experience. Int J Prev Med. 2016; 7: 99. https://doi.org/10.4103/2008-7802.188084 PMID: 27625764
10. Olagbuji BN, Atiba AS, Olofinbiyi BA, Akintayo AA, Awoleke JO, Ade-Ojo IP, et al. Prevalence of and risk factors for gestational diabetes using 1999, 2013 WHO and IADPSG criteria upon implementation of a universal one-step screening and diagnostic strategy in a sub-Saharan African population. Eur J Obstet Gynecol Reprod Biol. 2015; 189: 27–32. https://doi.org/10.1016/j.ejogrb.2015.02.030 PMID: 25855324
11. Agarwal MM, Dhatt GS, Othman Y. Gestational diabetes: differences between the current international diagnostic criteria and implications of switching to IADPSG. J Diabetes Complications. 2015; 29(4): 544–9. https://doi.org/10.1016/j.jdiacomp.2015.03.006 PMID: 25837380
12. National Collaborating Centre for Women’s and Children’s Health (UK). National Institute for Health and Care Excellence: Clinical Guidelines. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London: National Institute for Health and Care Excellence (UK) Copyright (c) 2015 National Collaborating Centre for Women’s and Children’s Health.; 2015.
13. Moses RG, Cefalu WT. Considerations in the Management of Gestational Diabetes Mellitus: "You Are What Your Mother Ate!". Diabetes care. 2016; 39(1):13–5. https://doi.org/10.2337/dci15-0030 PMID: 26696656
14. Lowe LP, Metzger BE, Dyer AR, Lowe J, McCance DR, Lappin TR, et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes care. 2012; 35(3):574–80. https://doi.org/10.2337/dc11-1687 PMID: 22301123
15. Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet. 2009; 373(9677):1789–97. https://doi.org/10.1016/S0140-6736(09)60515-8 PMID: 19465234
16. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP, MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008; 358(19):2003–15. https://doi.org/10.1056/NEJMoa0707193 PMID: 18463376
17. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PloS one. 2013; 8(5):e64585. https://doi.org/10.1371/journal.pone.0064585 PMID: 23724063
18. Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database Syst Rev. 2009 (3):Cd003395. https://doi.org/10.1002/14651858.CD003395.pub2 PMID: 19588341
19. Nicholson W, Bolen S, Witkop CT, Neale D, Wilson L, Bass E. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol. 2009; 113(1):193–205. https://doi.org/10.1097/AOG.0b013e318190a459 PMID: 19104375
20. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000; 343(16):1134–8. https://doi.org/10.1056/NEJM200010193431601 PMID: 11036118
21. Langer O, Yogev Y, Xenakis EM, Rosenn B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol. 2005; 192(1):134–9. https://doi.org/10.1016/j.ajog.2004.07.011 PMID: 15672015
22. Ijas H, Vaarasmaki M, Morin-Papunen L, Keravuo R, Ebeling T, Saarela T, et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG. 2011; 118 (7):880–5. https://doi.org/10.1111/j.1471-0528.2010.02763.x PMID: 21083860
23. Balani J, Hyer SL, Rodin DA, Shehata H. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study. Diabet Med. 2009; 26(8):798–802. https://doi.org/10.1111/j.1464-5491.2009.02780.x PMID: 19709150
24. Silva JC, Pacheco C, Bizato J, de Souza BV, Ribeiro TE, Bertini AM. Metformin compared with glyburide for the management of gestational diabetes. Int J Gynaecol Obstet. 2010; 111(1):37–40. https://doi.org/10.1016/j.ijgo.2010.04.028 PMID: 20542272
25. Bertini AM, Silva JC, Taborda W, Becker F, Lemos Bebber FR, Zucco Viesi JM, et al. Perinatal outcomes and the use of oral hypoglycemic agents. J Perinat Med. 2005; 33(6):519–23. https://doi.org/10.1515/JPM.2005.092 PMID: 16318615
26. Su DF, Wang XY. Metformin vs insulin in the management of gestational diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2014; 104(3):353–7. https://doi.org/10.1016/j.diabres.2013.12.056 PMID: 24768511
27. Jiang YF, Chen XY, Ding T, Wang XF, Zhu ZN, Su SW. Comparative efficacy and safety of OADs in management of GDM: network meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2015; 100(5):2071–80. https://doi.org/10.1210/jc.2014-4403 PMID: 25803270
28. Balsells M, Garcia-Patterson A, Sola I, Roque M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015; 350: h102. https://doi.org/10.1136/bmj.h102 PMID: 25609400
29. Tempe A, Mayanglambam RD. Glyburide as treatment option for gestational diabetes mellitus. J Obstet Gynaecol Res. 2013; 39(6):1147–52. https://doi.org/10.1111/jog.12042 PMID: 23718748
30. Mirzamoradi M, Heidar Z, Faalpoor Z, Naeiji Z, Jamali R. Comparison of glyburide and insulin in women with gestational diabetes mellitus and associated perinatal outcome: a randomized clinical trial. Acta Med Iran. 2015; 53(2):97–103. PMID: 25725178
31. Zeng YC, Li MJ, Chen Y, Jiang L, Wang SM, Mo XL, et al. The use of glyburide in the management of gestational diabetes mellitus: a meta-analysis. Adv Med Sci. 2014; 59(1):95–101. https://doi.org/10.1016/j.advms.2014.03.001 PMID: 24797983
32. Camelo Castillo W, Boggess K, Sturmer T, Brookhart MA, Benjamin DK Jr., Jonsson Funk M. Association of Adverse Pregnancy Outcomes With Glyburide vs Insulin in Women With Gestational Diabetes. JAMA Pediatr. 2015; 169(5):452–8. https://doi.org/10.1001/jamapediatrics.2015.74 PMID: 25822253
33. Behrashi M, Samimi M, Ghasemi T, Saberi F, Atoof F. Comparison of Glibenclamide and Insulin on Neonatal Outcomes in Pregnant Women with Gestational Diabetes. Int J Prev Med. 2016; 7:88. https://doi.org/10.4103/2008-7802.184502 PMID: 27413519
34. Ogunyemi D, Jesse M, Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract. 2007; 13(4):427–8. https://doi.org/10.4158/EP.13.4.427 PMID: 17669723
35. Silva JC, Bertini AM, Taborda W, Becker F, Bebber FR, Aquim GM, et al. Glibenclamide in the treatment for gestational diabetes mellitus in a compared study to insulin. Arq Bras Endocrinol Metabol. 2007; 51(4):541–6. PMID: 17684614
36. Anjalakshi C, Balaji V, Balaji MS, Seshiah V. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract. 2007; 76(3):474–5. https://doi.org/10.1016/j.diabres.2006.09.031 PMID: 17113179
37. Lain KY, Garabedian MJ, Daftary A, Jeyabalan A. Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. Am J Obstet Gynecol. 2009; 200(5):501.e1–6.
38. Mukhopadhyay P, Bag TS, Kyal A, Saha DP, Khalid N. Oral hypoglycemic glibenclamide: Can it be a substitute to insulin in the management of gestational diabetes mellitus? a comparative study. Journal of SAFOG. 2012; 4(1):28–31.
39. Nachum Z, Zafran N, Salim R, Hissin N, Hasanein J, Gam Ze Letova Y, et al. Glyburide Versus Metformin and Their Combination for the Treatment of Gestational Diabetes Mellitus: A Randomized Controlled Study. Diabetes Care. 2017; 40(3):332–7. https://doi.org/10.2337/dc16-2307 PMID: 28077460
40. Poolsup N, Suksomboon N, Amin M. Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis. PloS one. 2014; 9(10):e109985. https://doi.org/10.1371/journal.pone.0109985 PMID: 25302493
41. Malek R, Davis SN. Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus. Expert Opin Drug Metab Toxicol. 2016; 12(6):691–9. https://doi.org/10.1080/17425255.2016.1187131 PMID: 27163280
42. Ramos GA, Jacobson GF, Kirby RS, Ching JY, Field DR. Comparison of glyburide and insulin for the management of gestational diabetics with markedly elevated oral glucose challenge test and fasting hyperglycemia. J Perinatol. 2007; 27(5):262–7.
43. Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol. 2005; 193(1):118–24. https://doi.org/10.1016/j.ajog.2005.03.018 PMID: 16021069
44. Cheng YW, Chung JH, Block-Kurbisch I, Inturrisi M, Caughey AB. Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes. J Matern Fetal Neonatal Med. 2012; 25(4):379–84. https://doi.org/10.3109/14767058.2011.580402PMID: 21631239
45. Kimber-Trojnar Ż, Marciniak B, Patro-Malysza J, Skorzynska-Dziduszko K, Poniedzialek-Czajkowska E, Mierzynski R, et al. Is glyburide safe in pregnancy? Curr Pharm Biotechnol. 2014; 15(1):100–12. PMID: 24720590